Foundation News

Stay up-to-date with the most current news and information about the Crohn's & Colitis Foundation, as well as Crohn's disease and ulcerative colitis.

Crohn’s & Colitis Foundation and Pfizer, Inc. Announce Funding Awards to Reduce Health Disparities in Patients with Inflammatory Bowel Disease

NEW YORK, NY – The Crohn’s & Colitis Foundation (Foundation), in partnership with Pfizer Inc., has announced the results of a request for proposal (RFP) to reduce health disparities that exist around vaccine usage and health maintenance in patients with inflammatory bowel disease (IBD). 

October 7, 2020

ACG and The Crohn’s & Colitis Foundation Publish Entrustable Professional Activities for Advanced IBD Fellowship Training in the U.S.

The American College of Gastroenterology (ACG) and The Crohn’s & Colitis Foundation (the Foundation) are proud to announce their joint publication of “Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States” in both

August 25, 2020

Inflammatory Bowel Diseases—an official journal of Crohn’s & Colitis Foundation—announces new editorial leadership

After serving 4 years as co-Editor of the journal Fabio Cominelli, MD, PhD, has been named Editor-in-Chief and Sonia Friedman, MD, FACG, who is joining the editorial leadership, has been named Deputy Editor.

August 6, 2020

Patient groups warn: Administration policy encourages discrimination in health care

Washington, D.C. - Today 29 patient and consumer groups representing millions of people nationwide with pre-existing health conditions issued the following statement in response to administration’s final rule.

June 15, 2020

Crohn’s & Colitis Foundation and Pfizer, Inc. Issue RFP to Reduce Health Disparities in Patients with Inflammatory Bowel Disease

NEW YORK, NY – The Crohn’s & Colitis Foundation (Foundation), in partnership with Pfizer, Inc., announce a Request for Propo

June 2, 2020

Forty-Eight National Health Organizations Urge Congress to Provide Funding for COVID-19 Education for Chronic Illness Communities

NEW YORK, NY – Today, 48 national health organizations sent a letter to members of Congress urging them to fund critical education about COVID-19 and cancelled research activities as a result of the pandemic. 

April 16, 2020

Crohn’s & Colitis Foundation Welcomes New National Trustees

The Crohn’s & Colitis Foundation (the Foundation) is pleased to announce five new members of its National Board of Trustees, which oversees the management of the organization’s policies, practices, principles, affairs, funds, and property.

April 9, 2020

5 Major Advances in Inflammatory Bowel Disease (IBD) Treatment

Breakthrough research from the 2020 Crohn’s & Colitis Congress®, a meeting to transform IBD care.

January 23, 2020

Crohn’s & Colitis Foundation Selected for FDA MyStudies App Project

NEW YORK, NY – The Crohn’s & Colitis Foundation announced today that it was selected as one of two patient organizations to participate in an U.S.

September 27, 2019

New Research Reveals High Cost of Care for Inflammatory Bowel Disease Patients in the United States

NEW YORK, NY – The cost of care for inflammatory bowel disease (IBD) in the United States has increased significantly over the past five years, according to the results of the Crohn’s & Colitis Foundation’s cost of care study.

May 21, 2019

Crohn's & Colitis Foundation Unveils New Five-Year Research Agenda

NEW YORK, NY – Today, the Crohn’s & Colitis Foundation released its new five-year research agenda to address unmet needs in the inflammatory bowel disease (IBD) research community and provide a roadmap for not only the Foundation but also the IBD research community at-large.

May 16, 2019

Leading Gastroenterology Organizations Announce Funding to Improve Vaccine Utilization and Preventive Health Maintenance

New York, New York – The American College of Gastroenterology (ACG), the American Gastroenterological Association (AGA), and the Crohn’s & Colitis Foundation (Foundation), in partnership with Pfizer, Inc., have announced the results of a request for proposal (RFP) to address vaccine utilizati

March 8, 2019